Mikroscan
Mikroscan designs and manufactures compact FDA-registered robotic microscopes and dual-mode telemicroscopy/digital pathology systems that enable remote primary diagnosis, frozen section review, and ROSE procedures for hospitals, pathology labs, and government customers including the VA.
- Company typePrivate
- Founded2011
- HeadquartersCarlsbad, United States
- Headcount11–50
- GTM typeB2B
- OfferingHardware or Manufacturing
What Mikroscan does
Mikroscan Technologies, Inc. is a privately held medical device company founded in 2011 and headquartered in Vista, California, that designs, manufactures, and sells compact telemicroscopy and digital pathology systems for clinical and research pathology workflows. Its product portfolio centers on the L5 (a Class I FDA-registered remotely controlled robotic microscope enabling live telepathology for primary diagnosis including frozen sections and ROSE procedures) and the SL5 (a dual-mode system combining live robotic microscopy with whole-slide digital pathology scanning in a single desktop device roughly one square foot and 32 pounds). Both are available in the 5-20 Series configuration with a 20-slide autoloader delivering up to 420 slides per day, and the SL5-E serves as a CE-marked export variant. Images are output in non-proprietary TIF format for compatibility with third-party image analysis platforms (HALO by Indica Labs, Visiopharm) and cloud PIMS/LIS systems (Proscia, XIFIN, Fujifilm Synapse).
Mikroscan sells primarily through direct enterprise field sales to hospitals, academic medical centers, community hospitals, pathology laboratories, and government customers (including the Veterans' Health Administration), supplemented by channel partners (Micronix Systems for Northeast US distribution, Andwin Scientific for clinical trial supplies, Inspirata for non-exclusive digital pathology distribution). Revenue is generated through hardware sales, short-term rentals (under $70/day for the SL5), leases that can apply toward ownership, and post-warranty service and support contracts, with installation and training included in purchase pricing. Named customers include USC Keck School of Medicine, University of Mississippi Medical Center, University of Nebraska Medical Center, Henry Ford Health System, and the VA, with a disclosed 60% repeat business rate as of February 2025.
The company has raised approximately $10M+ in disclosed funding (including a Series A led by Peter Farrell of ResMed in 2015 and a 2018 round of ~$3.8M) and is led by President and CEO Martin Stuart, PhD (formerly of Aperio Technologies), with Gary Pace as Chairman, Susan Feiner as CFO, and Luis Malave as COO. Recent strategic activity centers on embedding Mikroscan hardware within AI-driven diagnostic workflows through partnerships with AIxMed (2024, cytology AI) and ROSEAId (2025, oncology workflows), alongside a peer-reviewed validation published in Archives of Pathology & Laboratory Medicine in March 2023.
Mikroscan firmographics
Firmographics- Name
- Mikroscan
- Legal name
- Mikroscan Technologies, Inc.
- Website
- https://mikroscan.com
- Company type
- Private
- Founded year
- 2011
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Mikroscan designs and manufactures compact FDA-registered robotic microscopes and dual-mode telemicroscopy/digital pathology systems that enable remote primary diagnosis, frozen section review, and ROSE procedures for hospitals, pathology labs, and government customers including the VA.
- Ownership category
- akta.pro rank
Mikroscan industry classification
Industry- Product category
- Digital Pathology and Telepathology Systems
- NAICS
- Surgical and Medical Instrument Manufacturing (339112), Electromedical and Electrotherapeutic Apparatus Manufacturing (334510)
- SIC
- Surgical & Medical Instruments & Apparatus (3841), Optical Instruments & Lenses (3827)
- akta.pro primary industry
- Microscopy, Imaging & Flow Cytometry Instruments (HLAGAIAE)
Keywords
Where Mikroscan is headquartered
LocationHeadquarters
- HQ city
- Carlsbad
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
Mikroscan business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Personnel, Supply Chain, Technology or R&D, Marketing or Sales, Operations, Infrastructure
Revenue model
- Hardware Sales: Sale of live telemicroscopy and digital pathology systems including L5, SL5, 5-20 Series, and SL5-E (export). One-time capital purchase with installation and training included.
- Short-Term Rental: Short-term rental program with systems available for less than $70 per day for the SL5 dual-mode system.
- Lease: Monthly lease payments applied toward ownership, providing alternative to capital purchase.
- Service and Support Contracts: 1-year warranty included with purchase covering service and support. After warranty period, service and support contracts available at affordable rates.
- Software/SaaS Partnerships: Partnership revenue through integrations with cloud platforms (Proscia), image analysis software (HALO, Visiopharm), and quality assurance services (QualityStar).
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Usage-based | Pay-as-you-go | SL5 Dual-Mode System Rental - Under $70/day |
| One time/ perpetual license | One time/ perpetual license | Purchase - Full System with 1-Year Service |
| Subscription | Monthly | Lease - Monthly Payments |
| One time/ perpetual license | One time/ perpetual license | High-Capacity Scanners - Market Comparison |
| Subscription | Annual | Service Contracts - Post-Warranty |
Go-to-market motion3 records
Distribution channels6 records
Marketing channels8 records
Mikroscan product offering
Product offeringCore offering
Mikroscan designs, manufactures, and sells compact, portable telemicroscopy and digital pathology systems that allow pathologists to remotely view and scan glass slides from any network-accessible location. Its core products are the L5 robotic microscope and the SL5 dual-mode system that combines live telemicroscopy and whole-slide imaging in a single device, sold primarily to hospitals, academic medical centers, and pathology labs through direct sales and channel partners.
Product overview
Mikroscan offers a suite of compact, portable, and affordable telemicroscopy and digital pathology systems designed to distribute pathology expertise regardless of location. The product portfolio centers on two core systems: the L5 (live telemicroscopy only) and the SL5 (dual-mode combining live telemicroscopy and digital pathology scanning). Both are available in 20-slide autoloader configurations as the 5-20 Series for higher-throughput workflows. The SL5-E is an export-only variant for markets outside the U.S. The L5 is FDA-registered as a Class I Light Microscope enabling clinical use including primary diagnosis, while the digital pathology scanning mode produces whole-slide images for research, archival, and quality assurance applications. All systems use non-proprietary TIF format for compatibility with third-party image analysis platforms.
Differentiator
Problem solved
Functional benefit
Products and services
- SL5 Dual-Mode Real-Time Telemicroscopy and Digital Pathology System Dual-mode system combining a live robotic microscope for clinical telepathology applications (ROSE, frozen sections, consultations) and a static digital pathology scanning mode for whole-slide image creation for research, archival, quality assurance, and education. Targets hospitals, academic medical centers, and pathology labs.
- L5 Real-Time Telemicroscopy System Class I FDA-registered remotely controlled robotic microscope that allows pathologists to perform traditional microscope evaluations of glass slide specimens from any network-accessible location using a true live feed of the glass slide. Capable of primary diagnosis and remote sign-out for cytology and frozen sections.
- 5-20 Series (20-Slide Autoloader for L5 and SL5) 20-slide capacity autoloader option available for L5 and SL5 systems. Features auto dock-and-lock, 4K-resolution monitor, double scanning speed (420 slides/day for 15x15mm specimens), high-resolution main camera, and 33% increase in bench depth. Mirrors traditional pathology folder workflow for higher-throughput environments.
- SL5-E Real-Time Telemicroscopy and Digital Pathology System Export-only (outside U.S.) dual-mode system identical to the SL5. CE marked and compliant with the European In Vitro Diagnostic Directive. Combines live robotic microscope and digital pathology scanning modes with 2X-40X objectives (60X optional) for non-U.S. clinical and research use.
Quantifiable outcome
- $1.8M annual savings to providers through frozen sections
- +9 more outcomes
Companies that use Mikroscan
Customer profileNamed customers8 records
Segments5 records
Ideal customer profiles5 records
Mikroscan technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration5 records
AI capability2 records
Feature10 records
Mikroscan partnerships and signals
Strategic signalPartnerships
13 partnerships are on record, tiered core and minor.
- ROSEAIdcorePartnership to optimize digital pathology workflows for cancer detection, announced April 2025.
- AIxMedcorePartnership to create cytology workflow solution combining AI capabilities with Mikroscan's telemicroscopy technology, announced March 2024.
- Micronix Systems, Inc.minorDistribution agreement for Northeast US region. Micronix has serviced microscopy needs of hospitals, pharmaceutical, research, and clinical laboratories for over 30 years with 1,300+ accounts.
- InspirataminorNon-exclusive distribution agreement for digital pathology solutions, announced March 2020.
- ProsciacoreFull integration of Mikroscan products into Proscia's cloud-based digital pathology workflow management platform. Cloud-based image storage, management, and analysis software leveraging AWS.
- Johns Hopkins University School of MedicinecoreResearch agreement to develop automated cytology analysis tools for ROSE (Rapid Onsite Evaluation of Adequacy). Led by Dr. Matthew T. Olson, Assistant Professor of Pathology, focusing on deep learning tools.
- QualityStarcoreQuality analytics and case review subscription service for Anatomic Pathology. Approved by American Board of Pathology as MOC QA Level IV program for subspecialty quality assurance review.
- HALO by Indica LabscoreHALO image analysis platform provides quantitative evaluation of digital pathology images. Pharmaceutical and medical research organizations worldwide use HALO for tissue-based research in neuroscience, metabolism, oncology, and toxicological pathology.
- VisioPharmcoreQuantitative Digital Pathology solution for biopharmaceutical companies, CROs, research institutions, and hospital diagnostic labs. ONCOTOPIX Diagnostics for cancer diagnostics with CE-IVD algorithms. 550+ licenses in 30+ countries.
- XIFINcoreXIFIN ProNet consultation and collaboration solutions enable secure, cloud-based exchange of healthcare images, data, and reports. Links healthcare stakeholders optimizing diagnostic and business decision-making.
- Gestalt DiagnosticscoreGestalt provides enterprise digital pathology solutions transforming labs from glass slides to electronic workflow. Their PathFlow platform complements Mikroscan's scanning capabilities with enterprise image management.
- Andwin ScientificminorEstablished 1950, Andwin specializes in clinical research supply chain and laboratory supplies management for life science organizations, providing a single source for study supplies and equipment.
- FUJIFILM Healthcare Americas CorporationcoreFujifilm's Synapse Enterprise Imaging portfolio provides healthcare professionals with cross-departmental imaging access. Mikroscan images compatible with Synapse Pathology for complete patient records.
Scale indicators6 records
Recent moves6 records
Expansion highlights5 records
Mikroscan competitors and assessment
Company assessmentDirect peers
- Leica Biosystems (Aperio): Leica acquired Aperio Technologies in 2012 and is the dominant provider of whole-slide scanners (Aperio AT2/GT450) used in pathology labs. Directly comparable to Mikroscan on digital pathology scanning, but with significantly higher throughput, broader installed base, and deeper integration with Leica/Danaher's staining and imaging portfolio.
- Hamamatsu Photonics: Manufacturer of the NanoZoomer series of digital pathology slide scanners, one of the most widely deployed WSI platforms globally. Comparable to Mikroscan as a slide-imaging scanner vendor serving clinical and research pathology workflows, with stronger throughput at higher price points.
- Grundium: Finland-based maker of compact, portable digital pathology scanners (Ocus) targeted at remote and small-lab use cases. Closely comparable to Mikroscan on the compact/portable scanner form factor and price-conscious mid-tier positioning.
- 3DHistech: Hungarian manufacturer of P1000, P250, and Panno whole-slide scanners plus integrated digital pathology workflow software. Directly comparable to Mikroscan as a WSI scanner vendor with both standalone and integrated workflow offerings.
- Philips Digital Pathology: Philips IntelliSite Pathology Solution is a high-volume whole-slide imaging platform deployed in large hospital networks. Comparable to Mikroscan on digital pathology scanning, though positioned for high-throughput enterprise deployments.
- KFBIO: Chinese manufacturer of digital pathology scanners (KF-PRO series) competing in the mid-tier and emerging markets with a price/throughput profile similar to Mikroscan's positioning.
Broad incumbents
- Roche (Ventana): Roche's Ventana division is a leading pathology diagnostics provider offering staining platforms and digital pathology workflow software (Virtuoso). Comparable to Mikroscan at the pathology workflow level, though Roche's scale and breadth in diagnostics far exceeds Mikroscan's narrow scanner focus.
- Olympus Life Science: Olympus is a major microscope and pathology imaging vendor whose BX series microscopes are the de facto standard that Mikroscan's L5 is positioned against for clinical frozen sections and primary diagnosis. Comparable as a microscopy incumbent, with significantly broader product breadth and global sales reach.
Emerging players
- Proscia: Cloud-native digital pathology workflow platform with Concentriq, integrated with Mikroscan scanners. Comparable as a digital pathology partner/competitor, though Proscia's primary differentiation is cloud software and AI workflow rather than imaging capture hardware.
Others
- Indica Labs: Developer of the HALO image analysis platform, a core integration partner for Mikroscan whole-slide images. Adjacent rather than directly competing — Indica Labs provides quantitative image analysis software that runs on top of Mikroscan and other WSI scanners.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
Mikroscan social profiles
Digital presenceMikroscan compliance and trust
Trust signalCompliance1 record
Mikroscan financial estimates
Financial estimateRevenue estimate
Valuation estimate
Mikroscan leadership team
Management profileNumber of profiles
Profiles11 records
Mikroscan funding detail
Funding detailFunding overview
Funding rounds3 records
Investors1 record
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Mikroscan M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Mikroscan
What does Mikroscan do?
Mikroscan designs, manufactures, and sells compact, portable telemicroscopy and digital pathology systems that allow pathologists to remotely view and scan glass slides from any network-accessible location. Its core products are the L5 robotic microscope and the SL5 dual-mode system that combines live telemicroscopy and whole-slide imaging in a single device, sold primarily to hospitals, academic medical centers, and pathology labs through direct sales and channel partners.
Is Mikroscan a public or private company?
Mikroscan is a private company. It is classified as venture growth investor backed and is currently operating.
When was Mikroscan founded?
Mikroscan was founded in 2011. It employs 11 to 50 people.
Where is Mikroscan based?
Mikroscan is headquartered in Carlsbad, United States, in the North America region.
How does Mikroscan make money?
Five revenue lines are on record. Hardware Sales are the primary driver. The others are short-Term Rental, lease, service and Support Contracts and software/SaaS Partnerships.
Who are Mikroscan's main competitors?
Direct peers on record are Leica Biosystems (Aperio), Hamamatsu Photonics, Grundium, 3DHistech, Philips Digital Pathology and KFBIO. Broad incumbents are Roche (Ventana) and Olympus Life Science. Proscia is listed as an emerging player. Indica Labs is listed as an others.
Does Mikroscan have an API?
No public API is recorded for Mikroscan.
What industry is Mikroscan in?
Mikroscan's product category is Digital Pathology and Telepathology Systems. Its primary akta.pro industry code is HLAGAIAE, Microscopy, Imaging & Flow Cytometry Instruments. Its NAICS code is 339112 and its SIC code is 3841.